GPhA bolsters lobbying team
The Generic Pharmaceutical Association appoints Gary Heimberg as VP-federal affairs and Jason Money as director of government affairs. Heimberg comes to GPhA from Akin Gump's public law and policy practice where he was a senior counsel; he has also worked for Sen. Edward Kennedy, D-Mass. Bruce Lott, who previously had the title of VP of government affairs, will serve as VP of state affairs. Prior to joining GPhA, Money served as health legislative assistant for Sen. George Allen, R-Va. He and Reilly O'Connor, who was recently promoted, will both serve as directors of government affairs...
You may also be interested in...
Use of per- and polyfluoroalkyl substances in cosmetic products appears to be declining, based on voluntary industry registrations with the US Food and Drug Administration. In any event, NGOs are gunning for PFAS' elimination, and the FDA says available data have yet to give a complete safety picture for PFAS used intentionally in cosmetics or present as impurities.
Exec Chat: How Edwards Lifesciences Deploys AI, Remote Monitoring To Help Doctors Make Life-Critical Decisions
Edwards Lifesciences’ head of critical care expects that “smart recovery” AI-driven products will grow the fastest in its critical care unit, which is expected to reach $800m in total revenues for 2021.
I.V. Korsuva now has an August FDA action date, which partner Vifor would commercialize in the ESRD dialysis setting while Cara works toward a broad anti-pruritus label for its oral tablet formulation.